Article: Read & Publish agreement confirmed between The Company of Biologists and EIFL

Access, Document, Open Decision-Support, Research

Read & Publish agreement confirmed between The Company of Biologists and EIFL

From Albania to Zimbabwe, researchers in 30 developing and transition economy countries can benefit from immediate and fee-free Open Access publishing in The Company of Biologists’ subscription journals following a Read & Publish agreement with Electronic Information for Libraries (EIFL).

This landmark agreement runs until 31 December 2023 and institutional members of EIFL-partner library consortia in eligible countries can participate free of charge. Researchers in eligible counties will be able to publish an uncapped number of Open Access research articles in Development, Journal of Cell Science and Journal of Experimental Biology without paying an article processing charge (APC). They will also benefit from free and unlimited access to the journals and their archives dating back to 1853.

Read Full Article

Article: The Company of Biologists commits to the Transformative Journal approach

Access, Document, Open Decision-Support, Research

The Company of Biologists commits to the Transformative Journal approach

The Company of Biologists has offered Open Access publishing options since 2004 and two of its five journals are already fully Open Access. The Transformative Journal strategy signals more clearly the journals’ commitment to move towards full Open Access, while a transition period allows the Company to provide publishing options that support all authors through this change in the publishing landscape.

Transformative Journals proactively champion Open Access publishing and have Open Access growth targets. Over the 2021-2024 transition period, the three journals aim to grow the proportion of Open Access research content by 5% year-on-year. When Open Access research content reaches 75%, the journals will flip to full Open Access. As The Company of Biologists transitions towards Open Access, authors will still have the same three routes to publication

Read Full Article